Marketing Authorisation

bligatory approval of a medicine to be marketed in the entire European Union, or in one or several of its Member States. It is granted after a scientific assessment by one or several competent authorities at the National or the European levels depending on the medicines’ type and scale of production. It is granted only if the quality, safety and efficacy criteria are met and if the benefit/risk balance of the medicine is positive.